Psilocybin slows down human reaction times and impairs executive function during the acute phase of use
The core finding of the meta-analysis is that psilocybin induces a dose-dependent slowing of reaction times across various cognitive domains, while leaving the accuracy of those responses largely intact. These…
Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants
The landscape of neuropsychopharmacology has reached a significant milestone with the publication of a comprehensive study directly comparing the physiological and psychological profiles of 3,4-Methylenedioxymethamphetamine (MDMA) and its primary metabolite,…









